Click on the indication in which you are interested. SUTENT has been
approved to treat 2 types of cancer:
Advanced kidney cancer. This is
also called advanced renal cell carcinoma (RCC)
A cancer of the digestive
(gastrointestinal) system called gastrointestinal stromal
tumor (GIST). SUTENT is used when the medicine
Gleevec® (imatinib mesylate) does not stop the cancer
from growing. It may also be used when you cannot take
Gleevec
Click below to confirm that you are a health care professional, and
go to the SUTENT HCP Web site: